Citation
Select
Kochiadakis GE, Igoumenidis NE, Hamilos ME, Tzerakis PG, Klapsinos NC, Chlouverakis GI, Vardas PE
Sotalol versus propafenone for long-term maintenance of normal sinus rhythm in patients with recurrent symptomatic atrial fibrillation
Am J Cardiol. 2004 Dec 15;94(12):1563-6
Citation
Select
Bellandi F, Leoncini M, Maioli M, Gallopin M, Dabizzi RP.
Comparing agents for prevention of atrial fibrillation recurrence
Cardiology Review 2002;19(9):18-21
Citation
Select
Bellandi F, Simonetti I, Leoncini M, Frascarelli F, Giovannini T, Maioli M, Dabizzi RP.
Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation
Am J Cardiol. 2001 Sep 15;88(6):640-5
Citation
Select
Bellandi F, Dabizzi RP, Niccoli L, Cantini F, Palchetti R.
[Propafenone and sotalol: long-term efficacy and tolerability in the prevention of paroxysmal atrial fibrillation. A placebo-controlled double-blind study] [Article in Italian] Original title: Propafenone e sotalolo: efficacia a lungo termine nella preven
G Ital Cardiol. 1996 Apr;26(4):379-90
Citation
Select
Bellandi F, Dabizzi RP, Niccoli L, Cantini F
Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation - Long-term safety and efficacy study
Munchener Medizinische Wochenschrift. 1996;138 (12):39-46
Citation
Select
Bellandi F, Dabizzi RP, Niccoli L, Cantini F
Propafenone and sotalol in the prevention of paroxysmal atrial fibrillation: Long-term safety and efficacy study
Curr Ther Res Clin Exp. 1995;56(11):1154-1168
Citation
Select
Antman EM, Beamer AD, Cantillon C, McGowan N, Friedman PL
Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs
J Am Coll Cardiol. 1990 Mar 1;15(3):698-707